Hasil Pencarian - Pinter A

  • Menampilkan 1 - 11 hasil dari 11
Perbaiki Hasil
  1. 1
    Brodalumab for the treatment of moderate-to-severe psoriasis: case series and literature review

    Brodalumab for the treatment of moderate-to-severe psoriasis: case series and literature review oleh Pinter A, Bonnekoh B, Hadshiew IM, Zimmer S

    Diterbitkan 2019-07-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  2. 2
    Calcipotriol/betamethasone dipropionate aerosol foam for the treatment of psoriasis vulgaris: case series and review of the literature

    Calcipotriol/betamethasone dipropionate aerosol foam for the treatment of psoriasis vulgaris: case series and review of the literature oleh Pinter A, Thormann H, Angeletti F, Jalili A

    Diterbitkan 2018-10-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  3. 3
    Conformational heterogeneity in V1/V2 domain affects the immunological properties of this region

    Conformational heterogeneity in V1/V2 domain affects the immunological properties of this region oleh Pinter A, Wu AZ, Neubert T, Burkhart MD, Honnen WJ

    Diterbitkan 2012-09-01
    Artikel
    Simpan ke Daftar
    Disimpan di:
  4. 4
    Neuropsychiatric symptoms in untreated Parkinson’s disease

    Neuropsychiatric symptoms in untreated Parkinson’s disease oleh Szatmari S, Illigens BM, Siepmann T, Pinter A, Takats A, Bereczki D

    Diterbitkan 2017-03-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  5. 5
    Cardiac dysautonomia in depression – heart rate variability biofeedback as a potential add-on therapy

    Cardiac dysautonomia in depression – heart rate variability biofeedback as a potential add-on therapy oleh Pinter A, Szatmari S Jr, Horvath T, Penzlin AI, Barlinn K, Siepmann M, Siepmann T

    Diterbitkan 2019-05-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  6. 6
    Characterization of V1V2-specific antibodies present in broadly neutralizing plasma isolated from HIV-1 infected individuals

    Characterization of V1V2-specific antibodies present in broadly neutralizing plasma isolated from HIV-1 infected individuals oleh Krachmarov C, Revesz K, Prattipati R, Reichman C, Lai Z, Honnen W, Li B, Derdeyn C, Pinter A

    Diterbitkan 2012-09-01
    Artikel
    Simpan ke Daftar
    Disimpan di:
  7. 7
    P04-09. Induction of cross-clade neutralizing antibodies with a prime/boost vaccine strategy focused on a neutralizing epitope

    P04-09. Induction of cross-clade neutralizing antibodies with a prime/boost vaccine strategy focused on a neutralizing epitope oleh Wang S, Seaman MS, Krachmarov C, Pinter A, Totrov M, Gorny MK, Jiang X, Cohen S, Hioe C, Cardozo T, Kong X, Zolla-Pazner S, Lu S

    Diterbitkan 2009-10-01
    Artikel
    Simpan ke Daftar
    Disimpan di:
  8. 8
    Detection of antibodies to the α4β7 integrin binding site on HIV-1 gp120 V2 loop using a novel cell adhesion assay

    Detection of antibodies to the α4β7 integrin binding site on HIV-1 gp120 V2 loop using a novel cell adhesion assay oleh Rao M, Karasavvas N, Pinter A, Liao H, Bonsignori M, Mathieson B, Zolla-Pazner S, Haynes BF, Michael NL, Kim JH, Alving CR, Peachman KK

    Diterbitkan 2012-09-01
    Artikel
    Simpan ke Daftar
    Disimpan di:
  9. 9
    P09-12. Autologous neutralizing antibodies in early subtype C HIV-1 infection target variable regions of envelope and drive multiple pathways of viral escape

    P09-12. Autologous neutralizing antibodies in early subtype C HIV-1 infection target variable regions of envelope and drive multiple pathways of viral escape oleh Gnanakaran S, Shaw GM, Pinter A, Blackwell JL, Allen SA, Mulenga J, Murphy MK, Haaland RE, Li B, Rong R, Hunter E, Robinson JE, Derdeyn CA

    Diterbitkan 2009-10-01
    Artikel
    Simpan ke Daftar
    Disimpan di:
  10. 10
    Construction of SHIVs expressing quaternary neutralization epitopes in Env and mimicking the neutralization phenotype of typical HIV-1 isolates

    Construction of SHIVs expressing quaternary neutralization epitopes in Env and mimicking the neutralization phenotype of typical HIV-1 isolates oleh Theis JF, de Parseval A, Honnen WJ, Phogat A, Ganapathi UC, Lai Z, Peng L, Reichman C, Moore PL, Morris L, Li Y, Hu S, Pinter A

    Diterbitkan 2012-09-01
    Artikel
    Simpan ke Daftar
    Disimpan di:
  11. 11
    Design of an HIV Env antigen that binds with high affinity to antibodies against linear, conformational and broadly neutralizing epitopes within V1/V2

    Design of an HIV Env antigen that binds with high affinity to antibodies against linear, conformational and broadly neutralizing epitopes within V1/V2 oleh Liao L, Bonsignori M, Hwang K, Moody AM, Park R, Crawford S, Chen H, Jeffries TL, Cooper M, Lu X, De R, Karasavvas N, Rerks-Ngarm S, Nitayaphan S, Kaewkungwal J, Tovanabutra S, Pitisuttithum P, Tartaglia J, Sinangil F, Kim J, Michael NL, Tomaras GD, Yang Z, Dai K, Pancera M, Nabel GJ, Mascola JR, Kwong PD, Pinter A, Zolla-Pazner S, Alam MS, Haynes BF

    Diterbitkan 2012-09-01
    Artikel
    Simpan ke Daftar
    Disimpan di:

Alat Pencarian: